Open Journal Systems

Complete resolution of refractory hypercalcemia following pneumonectomy in squamous cell carcinoma of the lung

Doraid Alrifai ()
Styliani Germanou ()
Brendan Tinwell ()
Edward Cetti ()
Ian Hunt ()
Tim Benepal ()


Patients with squamous cell carcinoma of the lung, amenable to complete resection, can suffer symptomatic humoral hypercalcemia of malignancy (HHM). This can compromise performance status and, ultimately, the candidacy for resection. Two cases highlighting initial pharmacological attempts at pre-operative correction of both clinical performance and elevated serum calcium levels are reported. Both patients received unsuccessful treatment leading to premature cessation of pharmacological measures and ultimately proceeded to complete tumor resection.


squamous cell carcinoma; lung cancer; HHM; humoral hypercalcemia of malignancy

Full Text:



Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990; 112(7): 499–504. doi: 10.7326/0003-4819-112-7-499.

Lumachi F, Brunello A, Roma A, Basso U. Cancer-induced hypercalcemia.Anticancer Res 2009; 29(5): 1551–1555.

Ratcliffe WA, Ratcliffe JG, Hutchesson ACJ, Bundred NJ. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia. Lancet 1992; 339(8786): 164–167. doi: 10.1016/0140-6736(92)90220-W.

Sriussadaporn S, Phoojaroenchanachai M, Ploybutr S, Plengvidhya N, Peerapatdit T, Nitiyanant W, Vannasaeng S, Vichayanrat A. Hypercalcemia ofmalignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid and hormone-related peptide. J Med Assoc Thai 2007; 90(4): 663–671.

Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP Jr., Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Eng J Med 1990; 322(16): 1106–1112. doi: 10.1056/NEJM19900419322-1603.

Danks JA, Ebeling PR, Hayman JA, Diefenbach-Jagger H, Collier FM, Grill V, Southby J, Moseley JM, Chou ST, Martin TJ. Immunohistochemical localization of parathyroid hormone-related protein in parathyroid adenoma and hyperplasia. J Pathol 1990; 161(1): 27–33. doi: 10.1002/path.1711610106.

Tanaka R, Okada M, Kajimura N, Otsubo K, Gyotoku M, Nagasaki K, Ekimoto H, Yamaguchi K. Triple paraneoplastic syndrome of hypercalcemia, leukocytosis and cachexia in two human tumor xeno-grafts in nude mice. Jpn J Clin Oncol 1996; 26(2): 88–94. doi: 10.1093/oxfordjournals.jjco.a023190.

Akai PS, Wong T, Chang-Poon V, Green F, Whitelaw WA, Hanley DA. Resectable bronchogenic carcinoma presenting with hypercalcemia: Tumor-associated granulomatous reaction and probable production of 1,25-dihydroxyvitamin D. Clin Invest Med 1989; 12(3): 212–216.

Tanaka H, Kobayashi S, Masaoka A, Honda S, Yamaguchi K. Hypercalcemia induced by parathyroid hormone-related protein from lung cancer tissue. Chest 1991; 100(5): 1451–1453. doi: 10.1378/chest.100.5.1451.

Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE collaborative group. J Clin Oncol 2008; 26(21): 3552–3559. doi: 10.1200/JCO.2007.13.9030.

Robinson CG, Patel AP, Bradley JD, DeWees T, Waqar SN, Morgensztern D, Baggstrom MQ, Govindan R, Bell JM, Guthrie TJ, Colditz GA, Crabtree TD, Kreisel D, Krupnick AS, Patterson A, Meyers BF, Puri V. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: A review of the National Cancer Data Base. J Clin Oncol 2015; 33(8): 870–876. doi: 10.1200/JCO.2014.58.5380.



  • There are currently no refbacks.

Copyright (c) 2018 Doraid Alrifai, Styliani Germanou, Brendan Tinwell, Edward Cetti, Ian Hunt, Tim Benepal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.